ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
ARS Pharmaceuticals Inc

ARS Pharmaceuticals Inc (SPRY)

11.76
-0.125
(-1.05%)
Closed December 17 4:00PM
11.55
-0.21
(-1.79%)
After Hours: 7:12PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
11.55
Bid
11.60
Ask
12.40
Volume
989,812
11.55 Day's Range 12.01
5.02 52 Week Range 18.51
Market Cap
Previous Close
11.885
Open
11.75
Last Trade
1
@
11.9
Last Trade Time
Financial Volume
$ 11,558,686
VWAP
11.6777
Average Volume (3m)
1,048,341
Shares Outstanding
97,185,475
Dividend Yield
-
PE Ratio
-21.02
Earnings Per Share (EPS)
-0.56
Revenue
30k
Net Profit
-54.37M

About ARS Pharmaceuticals Inc

ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for pa... ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
ARS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SPRY. The last closing price for ARS Pharmaceuticals was $11.89. Over the last year, ARS Pharmaceuticals shares have traded in a share price range of $ 5.02 to $ 18.51.

ARS Pharmaceuticals currently has 97,185,475 shares outstanding. The market capitalization of ARS Pharmaceuticals is $1.16 billion. ARS Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.02.

SPRY Latest News

ARS Pharmaceuticals Announces Filings for Approval of neffyยฎ in China, Japan and Australia

SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.78-13.353338334613.3313.611.55117165212.34913247CS
4-2.15-15.693430656913.714.911.5597603613.39675575CS
12-2.54-18.026969481914.0918.5111.55104834114.63898735CS
262.9834.7724620778.5718.517.55104541913.25552201CS
526.32120.8413001915.2318.515.0279130811.64656989CS
1566.27118.755.2818.512.558230418.63537234CS
2606.27118.755.2818.512.558230418.63537234CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUKKNukkleus Inc
$ 11.655
(738.49%)
174.06M
PRTGPortage Biotech Inc
$ 8.8678
(172.86%)
36.23M
OPTXSyntec Optics Holdings Inc
$ 3.55
(99.44%)
92.44M
PTPIPetros Pharmaceuticals Inc
$ 0.4976
(86.37%)
63.36M
LUXHLuxUrban Hotels Inc
$ 0.849899
(59.67%)
29.51M
VCNXVaccinex Inc
$ 1.41
(-61.37%)
758.95k
TNYATenaya Therapeutics Inc
$ 1.395
(-51.56%)
42.45M
ORKTOrangeKloud Technology Inc
$ 2.14
(-41.85%)
2.29M
RVPHReviva Pharmaceuticals Holdings Inc
$ 1.395
(-39.35%)
18.16M
DBGIDigital Brands Group Inc
$ 2.46
(-37.88%)
805.23k
RIMEAlgorhythm Holdings Inc
$ 0.0877
(8.27%)
1.13B
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.335
(-36.79%)
1.02B
GOEVCanoo Inc
$ 0.118
(7.08%)
388.43M
NVDANVIDIA Corporation
$ 130.39
(-1.22%)
259.4M
XTIAXTI Aerospace Inc
$ 0.0442
(8.33%)
222.55M

SPRY Discussion

View Posts
JJPK JJPK 3 months ago
Trading like news is eminent
๐Ÿ‘๏ธ0
stocksrising stocksrising 4 months ago
Iโ€™m In!! Going long, and selling naked Nov 12.5 puts ( almost $2 per put) GLTA
๐Ÿ‘๏ธ0
EnchantedTitan62 EnchantedTitan62 4 months ago
Good call on the inhalent, last week FDA approved. Moving up again today. 👍
👍️ 1
JJPK JJPK 6 months ago
Close to 3mil shares traded in the last minute of trading.
Whats Up.??
๐Ÿ‘๏ธ0
Monksdream Monksdream 8 months ago
SPRY under $10

๐Ÿ‘๏ธ0
erik007tc erik007tc 8 months ago
I believe the fda review/approval will be within 6 months.
👍️ 1
Monksdream Monksdream 9 months ago
SPRY over $10
Next day settlement begins 5/28 per SEC mandate
๐Ÿ‘๏ธ0
dodgerdog dodgerdog 9 months ago
Good News around the corner? 🙂
👍️ 1 🤑 1
gail gail 1 year ago
ah, should have held, lol
๐Ÿ‘๏ธ0
gail gail 1 year ago
not in as i hopped in something else, but watching now.
๐Ÿ‘๏ธ0
Pt3 Pt3 1 year ago
It not going up anytime soon but down Fda denied news
๐Ÿ‘๏ธ0
gail gail 1 year ago
why not?
๐Ÿ‘๏ธ0
Pt3 Pt3 1 year ago
Why buy
๐Ÿ‘๏ธ0
gail gail 1 year ago
i grabbed some today too.
๐Ÿ‘๏ธ0
makinezmoney makinezmoney 1 year ago
$SPRY:: Fabulous dump down to $2.60 here...............................


OKkkkkkkkkkkkkkkkkkkk.......... lets gooooooooooooooo


GO $SPRY
๐Ÿ‘๏ธ0
MiamiGent MiamiGent 2 years ago
SPRY Also in ...
ARS PHARMACEUTICALS INC
Pre-market the price per share is $7.85 +$0.10 (1.29%)

https://stockcharts.com/h-sc/ui?s=SPRY

Wedbush Reiterates Outperform on ARS Pharmaceuticals, Maintains $17 Price Target
BENZINGA
8:34 AM ET May-18-2023
Wedbush analyst Andreas Argyrides reiterates ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperform and maintains $17 price target.
๐Ÿ‘๏ธ0
MiamiGent MiamiGent 2 years ago
SPRY This is spraying profits all over my screen this morning! I have a very green screen! What's going on, I'm trying to glean.

https://stockcharts.com/h-sc/ui?s=SPRY
๐Ÿ‘๏ธ0
MiamiGent MiamiGent 2 years ago
SPRY $8.32 +$0.28 (+3.483%)
Moving up after waffling this morning
Volume
2,403,836
90 Day Avg. Vol.
927,230

https://stockcharts.com/h-sc/ui?s=SPRY
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock